Literature DB >> 2871216

Tubulopathy in nephrolithiasis: consequence rather than cause.

P Jaeger, L Portmann, J M Ginalski, A F Jacquet, E Temler, P Burckhardt.   

Abstract

To address whether a renal tubular dysfunction is encountered in a particular patient subgroup with urolithiasis, the following parameters of tubular function were measured in urine taken in the morning from 214 stone formers after fasting: pH, excretion of lysozyme and gamma-glutamyl transferase (gamma-GT); fractional excretion (FE) of glucose, insulin, Mg, K, and HCO3 after an alkali loading; and the renal threshold for phosphate (TmP/GFR). The following diagnoses were made in the patient group: primary hyperparathyroidism (N = 8), medullary sponge kidneys (N = 21), hyperuricemia (N = 10), cystinuria (N = 2), struvite stone disease (N = 6), idiopathic hypercalciuria of the absorptive (N = 25), dietary (N = 69) or renal (N = 7) type, and normocalciuric idiopathic urolithiasis (N = 66). In 31% of the patients TmP/GFR was below 0.80 mmole/liter and in 13% of the patients, FE HCO3 after alkali loading was above normal. Urinary excretion of lysozyme and that of gamma-GT both were elevated in 17% of the patients. FE glucose, FE insulin, FE Mg, and FE K were elevated in 8, 9, 3, and 7% of the patients, respectively. This study demonstrates that a significant number of stone formers present with signs of renal tubular dysfunction, primarily involving the proximal tubule since apparent leaks of phosphate and of bicarbonate were most frequently encountered. The defects were not specific for a given etiologic group of patients; on the other hand, occurrence was related to the presence of large stones in the pyelocaliceal system at the time data were gathered. Taken together these data suggest that the tubulopathy in nephrolithiasis is the consequence rather than the cause of the stone.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871216     DOI: 10.1038/ki.1986.35

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  The role of the papilla in idiopathic calcium oxalate nephrolithiasis.

Authors:  A Krautschick; T Esen
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

2.  Enzymuria as early marker of interstitial nephritis.

Authors:  A Neimark; A Fidirkin; I Celovalnikova
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

3.  Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.

Authors:  Eric N Taylor; Andrew N Hoofnagle; Gary C Curhan
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-26       Impact factor: 8.237

4.  Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin.

Authors:  M G Bianchetti; C Kanaka; A Ridolfi-Lüthy; H P Wagner; A Hirt; L Paunier; E Peheim; O H Oetliker
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

Review 5.  Animal models of kidney stone formation: an analysis.

Authors:  S R Khan
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.

Authors:  Waad-Allah S Mula-Abed; Huda S Al-Hashmi; Muhanna N Al-Muslahi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-02-12

Review 7.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

8.  Renal function in children with idiopathic hypercalciuria.

Authors:  F B Stapleton; L A Miller
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

9.  Urinary excretion of beta-2-microglobulin in patients with active metabolic stone disease.

Authors:  D Musialik
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

10.  Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.

Authors:  Przemyslaw Sikora; Sara Glatz; Bodo B Beck; Ludwig Stapenhorst; Malgorzata Zajaczkowska; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2003-08-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.